# CVE-2021-29790


## Metadata
| Published | Last Modified | Assigner | Version | Format |
| --------- | ------------- | -------- | ------- | ------ |
| 2022-07-18 18:15:00 | 2022-07-25 15:00:00 | psirt@us.ibm.com | 4.0 | MITRE | 

## Description
| Language | Description |
| -------- | ----------- |
| en | IBM Engineering Requirements Quality Assistant On-Premises (All versions) is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 203440. |

## Configurations
| Vulnerable | CPE 23 URI | CPE Name | Operator |
| ---------- | ---------- | -------- | -------- |
| True | cpe:2.3:a:ibm:engineering_requirements_quality_assistant_on-premises:*:*:*:*:*:*:*:* | [] | OR |

## CVSSv3 Information
| Score | Severity | Impact Score | Exploitability Score | Vector String | Version | Attack Vector | Attack Complexity | Privileges Required | User Interaction | Scope | Confidentiality Impact | Integrity Impact | Availability Impact |
| ----- | -------- | ------------ | -------------------- | ------------- | ------- | ------------- | ----------------- | ------------------- | ---------------- | ----- | ---------------------- | ---------------- | ------------------- |
| 5.4 | MEDIUM | 2.7 | 2.3 | CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N | 3.1 | NETWORK | LOW | LOW | REQUIRED | CHANGED | LOW | LOW | NONE |

## CVSSv2 Information
*** Not Provided/Calculated ***

## Problem Type
CWE-79

## References
| Name | Reference URL | Reference Source | Tags |
| ---- | ------------- | ---------------- | ---- |
https://www.ibm.com/support/pages/node/6604005|https://www.ibm.com/support/pages/node/6604005|CONFIRM|['Vendor Advisory']
| Name | Reference URL | Reference Source | Tags |
| ---- | ------------- | ---------------- | ---- |
ibm-engineering-cve202129790-xss (203440)|https://exchange.xforce.ibmcloud.com/vulnerabilities/203440|XF|['VDB Entry', 'Vendor Advisory']
